Jiangyin Jianghua Microelectronics Materials Co., Ltd.（603078） · Electronic Materials

Jianghua Micro: A Real but Mixed Wet-Chemicals Business Priced Like a Pure Semiconductor-Materials Platform

Jul 26, 2026·~24 min read

Quick ReadPlain-language overview · read this first

Jiangyin Jianghua Microelectronics Materials makes ultra-pure wet electronic chemicals for semiconductor, display, and solar manufacturers, and this report rates the stock Avoid. Semiconductor customers are now the company's largest end market, contributing roughly 58.7% of 2025 revenue (about CNY 711 million), ahead of display at 37.6% and solar at 3.6%. On the product side, photoresist-supporting chemicals (36% of revenue) carry a better 30.7% gross margin than ultra-pure reagents (64% of revenue, 26.1% margin), which is the mix shift bulls are counting on.

The fundamentals are solid but unspectacular. 2025 revenue rose 12.3% and attributable net profit rose 6.3%; the first quarter of 2026 continued that pace, with revenue up 16.9% and profit up 7.3%. Return on equity was only 5.44% in 2025 and net margin stayed under 9%, well short of what a true high-value materials platform would show. Operating cash flow has improved sharply, reaching CNY 182 million in 2025, but capex needs remain real as the company keeps expanding capacity.

The moat is genuine but narrower than the stock price implies. Customer qualification cycles are long and switching costs are real once a supplier is approved, but Jianghua Micro sits between two stronger comparisons: Shanghai Sinyang is broader and more semiconductor-pure, and Anji Micro is deeper in chemistry and far more profitable, while cleaner specialist peer Greenda trades at a noticeably lower multiple despite a similar niche.

That gap between quality and price is the core of the Avoid call. At a CNY 32.24 close, the stock traded around 116x trailing earnings, versus about 83x for Shanghai Sinyang, 71x for Anji Micro, and 63x for Greenda. The report's own valuation framework puts an ideal buy zone at CNY 12 to 15, an acceptable hold zone at CNY 17 to 21, and a clearly overvalued zone at CNY 24 to 28; the current price sits well above all three. The biggest risks are valuation compression toward peer multiples, semiconductor growth normalizing before margins widen enough to justify the premium, and an unfinished ownership transition as control shifts from Zibo state capital to Shanghai state capital.

The report's bottom line is that this is a real, improving business, but the market is already paying for years of successful fab penetration and mix upgrading that have not yet shown up in the numbers. The above is a summary of the report's views and does not constitute investment advice. Markets carry risk; invest with caution.

Lead
Jiangyin Jianghua Microelectronics is a wet electronic chemicals maker selling ultra-pure reagents and photoresist-supporting chemicals across semiconductor, display, and solar customers, with semiconductor now the largest end market at about CNY 711 million of 2025 revenue. The stock trades as if this were already a pure semiconductor-materials platform, but 2025 revenue rose only 12.3% and net profit 6.3% while the shares changed hands around 116x trailing earnings, well above stronger or more focused domestic peers Shanghai Sinyang (83x), Anji Micro (71x), and Greenda (63x). Research rating Avoid: real domestic-substitution progress and improving mix are being capitalized at a multiple that already assumes years of successful fab penetration the company has not yet delivered.

Full report

Prices in the article are as of publication; see the valuation band above for the live price.

Research Summary

Jianghua Micro is not a “China semiconductor pure play” in the way many momentum buyers seem to trade it. It is a wet electronic chemicals company whose real earnings engine still sits in a broader mix: semiconductor customers are now the largest end market, at roughly CNY 710.8 million of 2025 revenue, but display still contributed about CNY 455.3 million and solar another CNY 44.1 million. On the product side, the company remains more grounded in ultra-pure reagents than in the highest-value process chemistries: super-clean high-purity reagents contributed about CNY 775.1 million in 2025 revenue, while photoresist-supporting chemicals contributed about CNY 435.1 million. The latter carried the better gross margin, 30.7% versus 26.1%, which matters because the stock is increasingly being valued as if the whole business were becoming a higher-margin semiconductor-process specialist rather than a mixed wet-chemicals supplier.

That distinction explains most of the current investment debate. The market is trading Jianghua Micro on the same large narrative that has lifted much of China’s semiconductor-material chain: domestic substitution, customer qualification at local fabs, and the belief that export controls make local supply both more urgent and more valuable. The company itself frames wet electronic chemicals as a critical material class for integrated circuits, display panels, and photovoltaics, and cites industry data showing Chinese wet-chemical demand still growing in integrated circuits and displays even as solar becomes more cyclical. Its 2025 report also says that in integrated-circuit wet chemicals, foreign firms still dominate and domestic companies hold only about 10% of global share, which keeps the substitution runway conceptually large.

The problem is that the share price already prices in a great deal of that runway. Jianghua Micro’s 2025 revenue rose 12.3% and attributable net profit rose 6.3%. In the first quarter of 2026, revenue rose 16.9% and net profit 7.3%. Those are respectable numbers, but they are not the numbers of a business that obviously deserves a triple-digit TTM earnings multiple. Yet the stock closed at CNY 32.24 on 2026-07-24, and third-party quote pages showed a TTM P/E around 116x and a market cap around CNY 12.43 billion. The stock also hit a record high of CNY 59.50 on 2026-07-03 before falling back sharply. That pattern says the recent move was driven far more by multiple expansion and thematic excitement than by an earnings step-change.

The past explains why investors are willing to tell that story. Jianghua Micro has grown from a small private wet-chemical maker founded in Jiangyin in 2001 into China’s first listed specialist wet electronic chemicals company, listing on the Shanghai Stock Exchange in April 2017 at CNY 24.18 per share. Revenue rose from about CNY 490 million in 2019 to CNY 1.234 billion in 2025, while attributable net profit rose from about CNY 34.5 million to CNY 104.8 million over the same span. The business also broadened geographically and now describes itself as one of the few domestic suppliers able to serve semiconductor, flat-panel display, and new-energy customers with a full wet-chemicals lineup, backed by roughly 90,000 tons per year of ultra-high-purity wet-chemical capacity and more than 50 invention patents across the parent and subsidiaries.

The more interesting turn came in ownership and capital markets rather than in the income statement. The company’s controlling shareholder in 2025 was Zibo Xingheng Tusong, with the Zibo Municipal Finance Bureau as ultimate controller. In January 2026, Zibo Xingheng Tusong signed a conditional share-transfer agreement to sell 92.38 million shares, or 23.96% of Jianghua Micro, to Shanghai Fuxun Technology at CNY 20 per share, which would shift control from Zibo state capital to Shanghai state capital. Because of that pending control change, Jianghua Micro terminated its 2025 simplified-procedure private placement in February 2026 before filing materials with the exchange or the CSRC. This matters for two reasons. First, it tells investors the company is now part of a larger state-capital realignment story. Second, it means the market is paying up for a future strategy that the new controller has not yet had time to prove in the numbers.

The core bull-bear disagreement is therefore simple. Bulls see Jianghua Micro as an early-stage beneficiary of local fab qualification, with semiconductor revenue already the largest segment, better mix in photoresist-supporting chemicals, improving operating cash flow, and more room for rerating if the Shanghai state-capital handover accelerates capacity, customer access, or downstream integration. Bears see a mixed wet-chemicals business with only mid-single-digit to mid-teen earnings growth, a 2025 net margin of roughly 8.5%, and a valuation that already assumes years of successful penetration into harder semiconductor nodes. Both sides can point to real facts. The market’s current price mostly sides with the bulls. The income statement does not yet do the same.

Horizontally, Jianghua Micro does not sit where Anji Micro sits. Anji’s chemistry is deeper, its profitability is much higher, and its product set is concentrated in CMP and advanced wet-process chemicals rather than basic ultra-pure reagents plus supporting chemicals. Nor is Jianghua quite the same animal as Shanghai Sinyang, which has built a broader semiconductor-material platform around electroplating, cleaning, etching and photoresist-related products, and delivered much faster 2025 growth. The closest listed domestic peer is probably Greenda, another wet-chemical specialist with more concentrated exposure to high-purity supporting chemicals. Jianghua’s niche is broader end-market coverage and fuller wet-chemistry assortment, but narrower technology depth than the best semiconductor-material platforms and a less pure mix than the market narrative implies.

The fairest portrait is a domestic-substitution re-rating story with a real business underneath, but a market price running ahead of what the present earnings base can defend. In the language of style labels, Jianghua Micro is best described as a company in transition. The transition is real: semiconductor is becoming the anchor market, the product mix is inching toward higher-value chemistries, and ownership is moving toward a new state-capital framework. What is not yet proven is that this transition is happening fast enough, profitably enough, and durably enough to justify a valuation that already sits above several stronger or higher-quality peers.

Company History and Business Model

Jianghua Micro was founded on 2001-08-17 in Jiangyin, Jiangsu, and grew out of the demand for wet-process chemicals used in microelectronics manufacturing. By the time of its IPO, founder Yin Fuhua remained the central insider, holding 36.559% directly according to the IPO materials, which made the company look like a classic founder-led specialty chemical manufacturer rather than a state-incubated project. The early commercial logic was straightforward: domestic display, solar and later semiconductor manufacturers needed cleaner, more stable, specification-driven chemicals than traditional industrial reagent suppliers could provide, but the economics of the category still rewarded a company that could combine purification, formulation, quality control and local service rather than pure frontier chemistry alone.

The listing path was conventional and important. Jianghua Micro listed on the Shanghai Stock Exchange on 2017-04-10 after issuing shares at CNY 24.18. The IPO story was not “cutting-edge semiconductor materials champion” in today’s sense. It was closer to “listed specialist in wet electronic chemicals,” selling ultra-pure reagents and photoresist-supporting chemicals into several fast-growing electronics end markets. That matters because the stock’s current identity has drifted upward into a more semiconductor-pure narrative than the original business model supports.

The company’s development is easiest to understand in four stages.

The first stage was validation and regional build-out. In this period Jianghua Micro solved a practical supply problem for local electronics manufacturers: stable provision of ultra-pure acids, bases, solvents, etchants and cleaning chemistries with particle and impurity control far above commodity-chemical standards. The barriers were not glamorous, but they were real. The annual reports repeatedly stress the need for process control, purity, packaging, testing and customer qualification, and note that once approved by downstream manufacturers, supplier relationships tend to become sticky. That is the kind of moat specialty process-chemical companies usually start with.

The second stage was the public-market expansion phase after the 2017 IPO. The business then still had meaningful exposure to display, LED and solar alongside semiconductors, and the financial record shows a company growing but not yet compounding at elite rates. Revenue rose from CNY 490.4 million in 2019 to CNY 563.8 million in 2020 and CNY 792.1 million in 2021, while attributable net profit moved from CNY 34.5 million to CNY 58.2 million and then CNY 56.5 million. The growth is real, but what jumps out is the poor cash conversion in 2020 and 2021: operating cash flow was positive in 2019, then negative in both 2020 and 2021. This was a capacity-building, working-capital-hungry period rather than a mature cash-harvesting phase.

The third stage was balance-sheet reinforcement and mix improvement in 2022 through 2025. Revenue moved from CNY 939.2 million in 2022 to CNY 1.03 billion in 2023, CNY 1.10 billion in 2024 and CNY 1.23 billion in 2025. Attributable net profit jumped to CNY 105.8 million in 2022, held near that level in 2023, dipped to CNY 98.6 million in 2024, and recovered to CNY 104.8 million in 2025. Operating cash flow also turned strongly positive, reaching CNY 122.4 million in 2022, CNY 145.6 million in 2023, CNY 106.3 million in 2024 and CNY 182.0 million in 2025. The business reason was mix and discipline rather than sheer scale. In 2025, semiconductor revenue rose 22.0% and became the dominant end market, while photoresist-supporting chemicals continued to deliver a gross margin premium over ultra-pure reagents.

The fourth stage is the present transition period. It began with a stronger semiconductor mix but became a capital-markets story when ownership began to move from Zibo state capital to Shanghai state capital. In January 2026, the planned transfer of 23.96% of the company at CNY 20 per share would, if completed, shift control to Shanghai Fuxun and ultimate control to the Shanghai SASAC. In February 2026, Jianghua Micro terminated its 2025 simplified private placement because the control-change background had materially changed. By March the company had received SAMR’s no-further-review decision, and in June it disclosed a supplemental agreement adjusting parts of the transfer terms, including dividend-related transfer-price mechanics. In other words, Jianghua Micro is now a business in operational transition and a stock in governance transition at the same time.

The current business model is plain once stripped of market excitement. Jianghua Micro manufactures and sells wet electronic chemicals directly to customers. In 2025, almost all recognized revenue came from direct sales. End-market exposure was 58.7% semiconductor, 37.6% display, and 3.6% solar; product exposure was 64.0% ultra-pure reagents and 36.0% photoresist-supporting chemicals. The higher-value supporting-chemicals line earned a 30.7% gross margin, versus 26.1% for ultra-pure reagents. That spread is crucial. It tells you where the company’s future quality improvement would come from: not merely producing more tonnes, but tilting the mix toward more functional chemistries.

The moat is real, but narrower than the current valuation implies. The most durable defenses are customer qualification, process know-how, and local service density. Wet electronic chemicals are low-cost in customers’ total bill of materials but high-risk in yield impact, so once a supplier is qualified, replacement is slow. Jianghua Micro’s reports stress long certification cycles and long-term customer relationships. The company also benefits from breadth: it says it is one of the few domestic suppliers able to offer a full series of wet electronic chemicals across semiconductor, display and new-energy applications, and it emphasizes service advantages in the Yangtze River Delta and in western China through its Sichuan base. What it does not yet show is the kind of technology concentration or profitability that would make it look like a true high-end materials platform. Its 2025 ROE was only 5.44%, and net margin remained below 9%. That is good enough for a solid specialty manufacturer. It is not yet evidence of a deep, pricing-power-heavy moat.

Governance is the place where the story has become less founder-simple and more institutionally complicated. In 2025 the controlling shareholder was Zibo Xingheng Tusong, while founder Yin Fuhua still remained a major individual holder. The pending transfer to Shanghai Fuxun widens the watch list beyond the business itself: post-transfer capital allocation, board composition, and whether the new controller uses Jianghua Micro as a platform asset or merely a financial holding. So far the public disclosures show process, not proof.

The financial vertical record captures the central truth of Jianghua Micro. It is a company that has scaled revenue materially, improved mix gradually, and recently improved cash conversion, but has not yet converted those gains into high returns on capital. That is why the business can be real and the stock still expensive.

Metric	2021	2022	2023	2024	2025
Revenue	792.1m	939.2m	1,029.9m	1,099.2m	1,233.8m
Attributable net profit	56.5m	105.8m	105.3m	98.6m	104.8m
Operating cash flow	-49.3m	122.4m	145.6m	106.3m	182.0m
ROE	4.99%	9.68%	6.27%	6.35%	5.44%

Table sources: 2021 annual-report summary, 2022 annual-report summary, and 2025 annual report.

The table shows a business that became larger and more cash-generative, but not obviously more economically powerful. Revenue almost doubled between 2021 and 2025, while attributable profit not quite doubled and ROE stayed low. That usually means one of two things: either the company is still in a transition phase where capacity and customer validation are built ahead of margins, or the industry structure is simply not rich enough to produce high returns without much stronger product depth. Jianghua Micro is probably a mix of both.

Industry and Horizontal Comparison

China’s wet electronic chemicals market is large, still growing, and segmented in a way that flatters big narratives more than all individual companies deserve. Jianghua Micro’s 2025 annual report, citing the China Electronic Materials Industry Association, says China’s wet-chemicals demand across integrated circuits, displays and crystalline-silicon solar reached about 4.5097 million tonnes in 2024 and is expected to rise to about 4.6852 million tonnes in 2025, with semiconductor demand alone expected to rise from about 1.2535 million tonnes in 2024 to about 1.5431 million tonnes in 2025. It also gives the value-side picture: integrated-circuit wet chemicals were projected at about CNY 86.0 billion in 2025, ahead of display at CNY 80.1 billion and solar at CNY 56.3 billion. That mix is why the market increasingly fixates on semiconductor exposure rather than on the company’s legacy display and solar businesses.

The industry’s profit pool is not evenly distributed. At the low end sit volume reagents and simpler, more standardized chemistries. At the high end sit functional wet chemicals whose value is tied to process specificity, purity, defect control and customer co-development. Jianghua Micro straddles both. That helps stabilize the revenue base, but it also caps quality if higher-value chemistries do not become a much larger share of sales. The firm’s own numbers show that photoresist-supporting chemicals carry the better margin. The strategic question is whether that line becomes the company’s center of gravity or remains merely a profitable sleeve inside a larger reagent business.

This is also an industry where downstream bargaining power is formidable. Chipmakers, panel makers and major solar-cell producers run qualification-heavy procurement regimes. The supplier that wins a slot can keep it for a long time, but the customer chooses the pace. That makes the cycle unusual. Revenue can be sticky after qualification, but the timing of growth is still gated by customer certification and line ramps. The Semiconductor Industry Association has described semiconductor chemicals as having no known alternatives in the manufacturing process, which makes them critical; that does not mean every qualified supplier earns strong economics. Critical inputs are not automatically high-margin businesses.

Horizontally, Jianghua Micro should be compared in three circles.

The closest domestic strategic peer is Shanghai Sinyang. Shanghai Sinyang is the more convincing capital-markets proxy for China’s semiconductor-materials substitution theme because its platform is broader and more semiconductor-pure. Its 2025 revenue was about CNY 1.937 billion and attributable net profit about CNY 301 million, while semiconductor revenue alone reached about CNY 1.517 billion. Quote pages around the research date put its market cap near CNY 29.3 billion and TTM P/E around 83x. Customers choose Shanghai Sinyang because it looks less like a single-product chemical firm and more like a widening process-materials platform. The market prices that breadth, but even there the multiple is already rich. Jianghua Micro, by contrast, is smaller, less profitable, and more mixed across end markets, yet it was trading on a still higher TTM P/E.

The closest listed wet-chemicals specialist peer is Greenda. Greenda’s 2025 revenue was about CNY 625.8 million, and quote pages around the research date showed a market cap near CNY 7.58 billion and a TTM P/E around 63x. Greenda is the cleaner “specialty wet chemicals” comp. It is narrower than Jianghua Micro, smaller in revenue, but the market does not apply the same premium multiple. That matters because it shows Jianghua Micro’s valuation premium is not simply a sector phenomenon. Some of it is company-specific enthusiasm.

Anji Micro is the broader domestic-substitution reference point rather than a direct product comp. Its chemistry sits in CMP slurries, cleaning and advanced wet-process materials, with far deeper technology content and better economics. Anji’s 2025 revenue was CNY 2.504 billion and attributable net profit CNY 783.6 million; market cap around the research date was about CNY 58.35 billion and TTM P/E about 71x. Customers choose Anji not because it sells more chemistry in tonnes, but because it solves harder process problems. That is the benchmark Jianghua Micro’s bull case implicitly reaches for, but the present business does not occupy that place.

Peer snapshot	Jianghua Micro	Shanghai Sinyang	Greenda	Anji Micro
FY2025 revenue	1.234bn	1.937bn	0.626bn	2.504bn
FY2025 attributable net profit	104.8m	301m	n.a. in accessed primary filing excerpt	783.6m
Market cap as of 2026-07-24 or near-date	12.43bn	29.3bn	7.58bn	58.35bn
Current TTM P/E as of 2026-07-24 or near-date	116x	83x	63x	71x

Table sources: Jianghua Micro annual report and quote pages; Shanghai Sinyang annual-report summary and quote page; Greenda annual report excerpt and quote page; Anji Micro annual-report summary and quote pages.

The business reason behind these differences is clear. Shanghai Sinyang gets paid for platform breadth. Anji gets paid for higher technical depth and much stronger profitability. Greenda gets a healthy but lower multiple for being a cleaner specialist. Jianghua Micro has enough semiconductor exposure to attract thematic money, but not enough demonstrated profit density to justify the highest multiple in this peer sketch. Its ecological niche is best described as a domestic challenger with broad wet-chemistry coverage and improving semiconductor relevance, not as the category leader in advanced semiconductor process chemicals.

Current Fundamentals

The latest formal operating picture, as of the 2026 first-quarter report, is decent but not explosive. Revenue rose to CNY 321.9 million, up 16.9% year on year. Attributable net profit rose to CNY 28.8 million, up 7.3%. Operating cash flow rose to CNY 37.2 million, up 18.9%. These are healthy enough to support the argument that the business is still expanding, especially with semiconductor demand helping the mix, but they are also the numbers of a company still absorbing cost pressure. First-quarter R&D expense rose to CNY 16.37 million from CNY 12.27 million a year earlier, while financial expense rose to CNY 2.81 million from CNY 0.75 million, with interest expense more than doubling. Revenue is growing faster than profit because the company is still paying for growth.

The 2025 full-year mix already pointed the same way. Semiconductor revenue rose 22.0% to CNY 710.8 million and carried a 29.3% gross margin. Display grew only 5.6% to CNY 455.3 million. Solar fell 20.5% and was slightly loss-making at the gross level. Product mix improved, but only gradually: photoresist-supporting chemicals rose 14.1% and held a 30.7% gross margin, while ultra-pure reagents rose 12.6% with a 26.1% gross margin. The good news is that the company’s strongest pocket is the one the market cares about most. The less comfortable news is that the weaker pockets have not disappeared, and the stronger pocket is not yet big enough to redefine the economics of the whole company.

The market, by contrast, has been trading the stock as if the redefinition were already well under way. Jianghua Micro’s shares reached a record CNY 59.50 on 2026-07-03, at one point showing a one-year gain above 70%, before falling back to CNY 32.24 by 2026-07-24. The earnings path did not change nearly that rapidly. What changed was the narrative mix: semiconductor domestic substitution, the possibility of a more forceful strategy under a Shanghai state-capital controller, and a small-cap A-share market willing to pay up for materials names exposed to local fabs. That kind of move can last longer than fundamentals suggest, but it is still narrative first and results second.

The bull case has concrete evidence behind it. Semiconductor is now the largest end market. Photoresist-supporting chemicals are the more profitable product line. Operating cash flow strengthened sharply in 2025. The company describes itself as one of the few domestic full-series suppliers across semiconductor, display and new energy, and its website highlights roughly 90,000 tonnes per year of ultra-high-purity capacity and a growing patent estate. The ongoing control change could also open new industrial resources, financing channels or customer relationships, though this remains a possibility, not a result.

The bear case also has concrete evidence. Profit growth is still modest relative to the stock’s valuation. 2025 net margin was only about 8.5%, and 2025 ROE was 5.44%. Solar remains weak. Financial expense is rising. The simplified-procedure private placement was not completed; it was terminated before filing because the ownership backdrop changed. And the control transfer itself had not, in the latest public progress notice accessed for this report, been disclosed as fully closed. That means the market is paying for a future configuration of the company that is not yet fully visible.

Valuation and Risk

The headline valuation is the central issue. At CNY 32.24, Jianghua Micro was trading around 116x TTM earnings and about 6.2x book value on quote pages current to the research date. Using 2025 attributable profit of CNY 104.8 million and 385.64 million shares outstanding, trailing EPS was about CNY 0.272, which independently lands in the same neighborhood, roughly 119x. On either definition, this is not a normal specialty-chemical multiple. It is a narrative multiple.

The cash-flow passthrough check softens the valuation only slightly. Over 2021-2025, operating cash flow was negative in 2021 but strongly positive thereafter, with 2025 OCF of CNY 182.0 million against attributable profit of CNY 104.8 million. 2025 reported cash capex for fixed assets and intangibles was only CNY 27.0 million, but that likely understates true maintenance-plus-growth burden in a chemical plant still expanding capacity and carrying meaningful depreciation of about CNY 118.8 million plus amortization. A reasonable owner-earnings view is therefore somewhere between reported net profit and operating cash flow. Even on a generous owner-earnings estimate near CNY 117 million, the stock would still trade above 100x owner earnings. The gap versus headline P/E is not the real problem. The real problem is that both measures are expensive.

The balance sheet is sound enough for the business, but it does not rescue the valuation. At the end of 2025, Jianghua Micro had about CNY 525.6 million in cash and cash equivalents. Long-term borrowings including current portions were about CNY 442.5 million, while shareholder equity attributable to the parent was about CNY 1.964 billion. Gross debt to equity was therefore in the low-20% range. That is manageable. It means Jianghua Micro is not a balance-sheet accident. It does not mean the stock is cheap.

The peer check points the same way. Shanghai Sinyang, with stronger 2025 growth and broader semiconductor-material platform exposure, traded around 83x TTM earnings. Greenda traded around 63x. Anji, with much higher technology depth and far stronger profitability, traded around 71x. Jianghua Micro traded above all of them. A company can deserve a premium if it has better growth, stronger moat, or superior capital efficiency. Jianghua Micro has none of those on the disclosed 2025 and 2026 first-quarter numbers.

That leads to the valuation scenarios below. They are not price targets in the brokerage sense. They are a framework for testing what must go right for the current price to make sense.

Dimension	Conservative	Base	Optimistic
Revenue and margin assumptions	Semiconductor growth slows; 2026-2028 revenue CAGR about 8%; net margin holds around 8.5%–9.0%	Semiconductor mix keeps improving; 2026-2028 revenue CAGR about 11%; net margin reaches around 10%	Qualification and ramp go right; 2026-2028 revenue CAGR about 14%; net margin reaches around 11%–12%
Cash-flow assumptions	Owner earnings around CNY 130m by 2028	Owner earnings around CNY 165m by 2028	Owner earnings around CNY 210m by 2028
Multiple assumptions	40x owner earnings	45x owner earnings	50x owner earnings
Present-value range per share	CNY 12–15	CNY 17–21	CNY 24–28
Key catalysts	Stable fab orders; no disruption from control change	Rising semiconductor mix; better margin from supporting chemicals	Faster local-fab penetration; cleaner transition to Shanghai state-capital control
Key risks	Solar and display drag persists; valuation compresses	Margin gains disappoint; share dilution or capex rises	Market overstates penetration; multiple falls despite earnings growth
Implied upside from current price	downside, not upside	downside, not upside	upside still limited unless all major assumptions hold
Permanent-loss risk	trigger: valuation mean-reverts toward peer levels before profit base expands	trigger: semiconductor mix improves too slowly to justify premium	trigger: current price still bakes in more than the optimistic case can bear

Scenario basis: current share count from annual report; current price from 2026-07-24 close; scenario assumptions grounded in FY2025 segment mix, Q1 2026 growth, peer multiples, and the still-moderate profitability of the current business.

The business interpretation is blunt. Even the optimistic case produces a value range below the 2026-07-24 close. That does not prove the stock must fall on any fixed schedule. A-share narratives can remain overextended. It does mean the market is pre-spending future success.

The margin-of-safety recheck is therefore unfavorable. The current price sits at a steep premium to the conservative scenario, so the margin of safety is zero. The most fragile assumption in the base case is not revenue growth by itself; it is the expectation that a mixed wet-chemicals company can both improve mix and retain a premium multiple at the same time. If that assumption is cut to 70%, the base-case value falls toward the mid-teens. If earnings were flat for three years and the stock merely de-rated to a still-generous 50x earnings multiple, annualized returns from the current price would be poor. This is a good-company-but-bad-price setup.

The main permanent-loss risks are specific. The first is valuation compression, and it is the highest-probability risk. If the market decides Jianghua Micro should trade closer to Greenda or a discount to Shanghai Sinyang, the stock can fall substantially even if the company keeps posting double-digit revenue growth. The second is slower-than-priced semiconductor penetration. 2025 segment data already show that semiconductor is carrying the story while display and solar are not. If semiconductor growth normalizes before margins widen materially, the equity loses both its growth premium and its thematic purity. The third is governance transition risk. The control transfer is strategic, but until it is fully closed and a post-transfer strategy becomes visible, investors are underwriting an unfinished story. The fourth is financial drag from expansion. Interest expense is already rising, and the company disclosed in July 2026 that it planned to inject CNY 90 million of self-funded capital into its Zhenjiang subsidiary to optimize capital structure and support development. That may be sensible, but it is another reminder that Jianghua Micro still needs capital to grow into the story the market is telling.

Cross-Synthesis Summary

Looking across the whole journey, Jianghua Micro has proved one thing clearly: it can build a credible domestic specialty-chemical manufacturer for electronics applications and keep upgrading it. That is not trivial. Many chemical companies can purify, blend or package. Far fewer can do it under electronics-grade discipline, survive qualification cycles, and remain relevant across several electronics end markets for two decades. The company’s growth from roughly CNY 490 million of revenue in 2019 to CNY 1.234 billion in 2025, together with semiconductor becoming the largest market and cash generation improving meaningfully, shows real industrial capability.

What the record does not show is that Jianghua Micro has already become a high-return, high-moat semiconductor materials platform. The long-run returns are still modest. 2025 ROE was 5.44%. Net margin was under 9%. Product economics are better in photoresist-supporting chemicals than in ultra-pure reagents, but the higher-value pocket is still only about 36% of main business revenue. The success to date has come from a mix of era tailwinds, customer stickiness, management persistence, and domestic-substitution demand. It has not yet come from the kind of dominant technology position that would let the company outrun the industry structurally.

Horizontally, Jianghua Micro’s real advantage is breadth with relevance. It can serve semiconductor, display and solar customers with a wide assortment of wet chemistries, and it has the local manufacturing and service footprint to matter in China’s electronics clusters. That gives it staying power. Its weakness versus the better peers is just as clear. Shanghai Sinyang is broader and more semiconductor-pure. Anji is deeper and more profitable. Even Greenda, though smaller, gives investors a cleaner specialty-wet-chemicals comparison. Jianghua Micro therefore occupies an awkward middle ground: better than a commodity chemical supplier, not yet a top-tier advanced semiconductor-material platform. Markets often overpay for companies in this middle zone when the headline theme is right.

The stock price today rewards future success more than past success. The market is effectively assuming that the company’s semiconductor penetration will continue, that the product mix will keep shifting toward more profitable supporting chemicals, that the control transfer to Shanghai state capital will be an operational positive, and that none of this will require a valuation reset. That is a lot to assume at once. The market is most likely misjudging the speed at which a real but mixed business can become the purer, richer semiconductor-material story investors want it to be.

The key variables differ by horizon. Over the next year, the market will care most about semiconductor revenue growth, gross-margin progression, and what the new controlling shareholder actually does after the transaction progresses. Over three years, the decisive question is whether photoresist-supporting and other functional chemistries become a much larger share of sales and profits. Over five years, the question is whether Jianghua Micro becomes a real platform in domestic semiconductor wet-process materials or remains a broader wet-electronic-chemicals supplier with one fast-growing pocket. The first path can support a premium. The second can support a business, but not necessarily this multiple.

A better investment case would require one of two things. Either the price falls enough to embed a true margin of safety, or the earnings base rises enough that today’s valuation looks less extreme. Concretely, that would mean several quarters in which semiconductor growth remains above company average, photoresist-supporting chemicals continue widening their gross-margin premium, operating cash flow stays consistently above net profit, and the post-transfer strategy under Shanghai state capital becomes observable rather than speculative. A contrary path would force a re-examination: two quarters of gross margin below 26%, semiconductor growth dropping toward single digits, rising leverage without a clear payoff, or a messy control transition that stalls resource integration.

Bull reasons

Semiconductor became the largest end market in 2025 at about CNY 710.8 million, growing 22.0% year on year, which shows the domestic-substitution story is already visible in segment revenue, not just in marketing language.
Photoresist-supporting chemicals earned a 30.7% gross margin in 2025 versus 26.1% for ultra-pure reagents, so mix improvement can still lift quality if that category keeps taking share.
Operating cash flow improved to CNY 182.0 million in 2025 and stayed positive in Q1 2026, suggesting the business is no longer in the weak-cash-conversion phase seen in 2021.
The company describes itself as one of the few domestic full-series wet-electronic-chemicals suppliers across semiconductor, display and new-energy applications, which gives it cross-sell and customer-density advantages.

Bear reasons

At about 116x TTM earnings and 6.2x book, the stock trades above stronger or higher-quality domestic peers such as Shanghai Sinyang, Greenda and Anji.
2025 attributable net profit rose only 6.3%, and Q1 2026 net profit rose only 7.3%, far below what the current multiple implies.
Solar revenue fell 20.5% in 2025 and was slightly loss-making at the gross level, which shows the company is still carrying weaker end-market exposure behind the semiconductor story.
The 2025 simplified private placement was terminated before filing because the control-change backdrop had materially shifted, and the transfer to Shanghai Fuxun was still, in the latest public notices accessed here, a progress story rather than a closed result.
Financial expense rose sharply in Q1 2026, and the group is still sending capital into expansion entities such as the planned CNY 90 million injection into the Zhenjiang subsidiary.

Pre-mortem

The most plausible 50% drawdown script is a classic double hit. By early 2027, semiconductor segment growth slips into the low teens as local fab qualification takes longer than investors hoped, while display stays flat and solar remains weak. Gross margin drifts back toward 26%, net margin stalls near 8%, and the market stops paying 100x-plus earnings for a mixed wet-chemicals supplier. If the multiple falls toward 50x on flat-to-moderately-higher earnings, the share price can halve without any accounting shock.

A second script runs through the control change. The transfer to Shanghai Fuxun closes, but the new controller focuses first on governance and asset alignment rather than immediate operating acceleration. The simplified placement is gone, capex and working-capital needs continue, and investors discover that “new owner” is not the same thing as “new earnings model.” In that case the narrative premium fades before the business mix upgrades enough to replace it.

The bottom line is that Jianghua Micro is a real company with real semiconductor exposure, not a shell built around a fashionable theme. It has proven it can scale, keep customers, and gradually improve mix. What it has not proven is that it can do those things fast enough to defend a valuation that already discounts a much richer future. The stock may remain volatile and theme-driven for longer than valuation logic would suggest. That is not the same as being investable at the current price.

I would change my mind if either the price fell to a level that offered protection against a de-rating, or if the company delivered several consecutive quarters showing that semiconductor-led mix improvement is strong enough to move the whole business economics, not just one segment. Until then, the asymmetry is poor: operationally sound enough to avoid a disaster thesis, but priced too high to offer a disciplined entry.

【Company-profile scores】

Fundamental quality: medium
Growth: medium
Moat: medium
Financial soundness: medium
Management credibility: medium
Valuation attractiveness: low
Risk level: high
Suitable investor type: not suitable for the general investor

【Investment rating】

Rating: Avoid
One-line thesis: Real domestic-substitution progress is being capitalized at a multiple that already assumes years of successful fab penetration and mix upgrading.

【Ideal Buy Price】12–15 CNY Basis: a ≥20% margin of safety below the value implied by the conservative owner-earnings scenario in the valuation framework above.

Acceptable hold price: 17–21 CNY
Clearly overvalued price: 24–28 CNY
Current-price classification: clearly overvalued
Whether to wait for a better price: yes. A disciplined entry would require the stock to move back into the low-to-mid teens, or evidence that semiconductor-led earnings are compounding much faster than the current 2025 and Q1 2026 run rate. The opportunity cost of waiting is missing a narrative squeeze; the benefit is avoiding a large valuation de-rating.
Target holding horizon: 3–5 years, but only from a materially lower entry price
Expected annualized return: conservative scenario negative from the current price; base scenario roughly negative high-single digits; optimistic scenario roughly flat to low-single digits
Max-loss risk: about 50% if the stock de-rates toward 50x earnings before the profit base materially expands
Reassessment-trigger signals: semiconductor revenue growth below 10% for two consecutive quarters; consolidated gross margin below 26% for two consecutive quarters; operating cash flow trailing net profit by more than 20% over a rolling year; a control-transfer delay or reversal; materially larger-than-expected equity dilution or debt-funded capex

【Valuation Range】

current: 32.24 (close as of 2026-07-24)
bear (conservative · ideal buy zone): [12, 15]
base (fair · acceptable hold zone): [17, 21]
bull (optimistic · above the clearly-overvalued line): [24, 28]

Key data tables

Operating snapshot	FY2025	Q1 2026
Revenue	1,233.8m	321.9m
Attributable net profit	104.8m	28.8m
Operating cash flow	182.0m	37.2m
Gross margin on main business	27.79%	n.a. in quarterly filing
Semiconductor revenue	710.8m	n.a. in quarterly filing
Photoresist-supporting chemicals gross margin	30.72%	n.a. in quarterly filing

Table sources: FY2025 annual report and 2026 first-quarter report.

This compact table is the heart of the story. Jianghua Micro’s operating trend is positive. What is missing is evidence of a step-change large enough to justify how far the stock has already re-rated.

Tracking indicator	Recent reference point	Alert threshold
Semiconductor revenue growth	22.0% in FY2025	below 10% for two quarters
Main-business gross margin	27.79% in FY2025	below 26% for two quarters
Supporting-chemicals margin premium over reagents	4.58 ppt in FY2025	below 2 ppt
Operating cash flow / attributable net profit	1.74x in FY2025	below 0.8x on rolling 12 months
Gross debt / parent equity	about 22% at FY2025	above 35%
Financial expense growth	sharply higher in Q1 2026	persists faster than revenue growth
Valuation versus peers	Jianghua at about 116x vs peers at about 63x-83x-71x	premium widens without faster earnings
Next earnings date	2026-08-26 expected	delay or major guidance miss

Table sources: annual report, first-quarter report, quote pages, and earnings-calendar pages.

A useful dashboard for Jianghua Micro should not be too clever. The stock will respond first to semiconductor mix, margin, and valuation compression risk. Those are the three dials that matter most.

Research uncertainties

The biggest blind spot is customer naming. The public filings accessed for this report disclose mix by market type, not a detailed named-fab customer list, so the report can judge qualification breadth only indirectly from segment growth, product claims, and company descriptions.

The second blind spot is the terminated 2025 simplified placement. Public materials accessed here verify the proposal, its strategic purpose, and its termination, but not a completed size, pricing or dilution effect because the deal was terminated before exchange and CSRC filing.

The third blind spot is the control transfer’s end-state. The latest public progress notices accessed here showed a signed transfer agreement, a SAMR no-further-review decision, and a supplemental agreement, but not definitive completion and post-transfer operating results.

The fourth blind spot is maintenance capex. Reported 2025 cash capex was low relative to depreciation, so owner-earnings valuation necessarily uses judgment rather than a mechanically precise maintenance-growth split.

Sources used most heavily

Primary materials drove the analysis: Jianghua Micro’s 2025 annual report, 2026 first-quarter report, and the February 2026 termination notice for the simplified placement. For peer comparisons, the report relied mainly on Shanghai Sinyang’s 2025 annual-report summary, Anji Micro’s 2025 annual-report summary, and Greenda’s 2025 annual report excerpt, alongside dated quote pages for current valuation context. Industry sizing relied chiefly on Jianghua Micro’s own 2025 report citation of the China Electronic Materials Industry Association and the SIA supply-chain submission for the criticality of process chemicals.

Other tickers mentioned

300236.SHE — Shanghai Sinyang, the closest domestic semiconductor-materials peer for judging whether Jianghua Micro is also priced for years of fab-penetration success
603931.SHG — Greenda, a closer listed wet-chemicals specialist used to test whether Jianghua Micro’s valuation premium is justified
688019.SHG — Anji Micro, a broader domestic-substitution reference point with stronger technology depth and profitability
AVTR.US — Avantor, a global process-chemicals reference for industrial and life-science high-purity chemicals rather than a direct China A-share comp
4047.TSE — Kanto Denka, a Japanese electronic-materials reference for global wet-chemicals and semiconductor-materials competition

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.

Mentioned Tickers

300236 603931 688019 AVTR 4047

Baillie Framework · Ten Questions for Growth Investing

Hunting ten-year five-baggers among great growth stocks — pressing the upside question: "Can it get much bigger?"

How high is its market ceiling — is it growing a slice of an existing pie, or creating an entirely new market?3/10

Jianghua Micro is expanding a slice of an existing, policy-supported market, not creating a new one. Wet electronic chemicals — the ultra-pure acids, bases, solvents and photoresist-supporting reagents used in chip, display and solar fabrication — are a mature, decades-old materials category; what is actually shifting is which suppliers serve China's fabs, not whether the category itself exists. The underlying report, citing the China Electronic Materials Industry Association, puts total mainland China wet-electronic-chemicals demand at about 4.5097 million tonnes in 2024, rising to about 4.6852 million tonnes in 2025 — a modest ~3.9% year-on-year increase — which lines up with independent coverage of the same industry-association data. On the value side the report puts 2025 China demand at about CNY 86.0 billion for integrated-circuit wet chemicals, CNY 80.1 billion for display, and CNY 56.3 billion for solar — a combined market above CNY 220 billion.

Against that base, Jianghua Micro's entire 2025 revenue of CNY 1,233.8 million is roughly 0.6% of the combined market and about 0.8% of the IC wet-chemicals segment specifically (its own CNY 710.8 million of semiconductor revenue against an CNY 86.0 billion IC segment). Its disclosed capacity — about 90,000 tonnes a year, plus a 37,000-tonne Zhenjiang expansion project — comes to roughly 2.7% of national volume even after the expansion completes. That is the profile of a company taking share inside a large, slow-growing aggregate, not inventing a new spending category. The company's own 2025 annual report frames it exactly this way: domestic suppliers hold only about 10% of the global integrated-circuit wet-chemicals market, which is an import-substitution opportunity, and Beijing is actively backing that substitution — the Ministry of Industry and Information Technology's 2025-2026 Petrochemical and Chemical Industry Steady Growth Work Plan explicitly names electronic-chemicals breakthroughs as a supply-chain priority. That is a real tailwind for gaining share of an existing pie, not evidence of a new one being created.

Within that ceiling there is real unevenness worth separating out, because it is where almost all of the bull case actually lives. IC-linked demand is growing much faster than the aggregate — the same industry data show IC wet-chemical volume rising from roughly 1.25 million tonnes in 2024 to about 1.54 million tonnes in 2025, an increase well above the ~4% blended rate — and Jianghua's own 2025 segment data track the same split: semiconductor revenue up 22.0%, display up only 5.6%, and solar down 20.5% and slightly loss-making at the gross level. So the real ceiling question is not "how large can wet chemicals become," it is "how much of the faster-growing IC sub-segment can Jianghua actually capture against stronger platform peers like Shanghai Sinyang and Anji Micro." That is a bounded, share-gain ceiling with a credible multi-year runway behind it, not a market-creation story, and the current 116x trailing multiple is priced as if it were closer to the latter.

Jul 26, 2026
Can its revenue at least double over the next five years? Is that growth driven mainly by volume, price, or new businesses?4/10

Doubling revenue in five years is not the report's own base case, and the recent trend is decelerating rather than accelerating toward that bar. Revenue grew from about CNY 490 million in 2019 to CNY 1,233.8 million in 2025, but that six-year run compresses into two very different three-year stretches: roughly 24% annualized from 2019 to 2022 (CNY 490.4 million to CNY 939.2 million) and only about 9.5% annualized from 2022 to 2025 (CNY 939.2 million to CNY 1,233.8 million). 2025 itself grew 12.3% and Q1 2026 grew 16.9%, both respectable but well inside that slower, more recent band.

Doubling in exactly five years requires a sustained 14.87% annual growth rate (2^(1/5) − 1). The report's own 2026-2028 scenario table tops out at an "optimistic" revenue CAGR of about 14% — already short of that bar over three years — and even extrapolating that optimistic rate across a full five years (an extension well beyond what the report actually models) compounds to about 1.93x, still short of a double. The base-case assumption of about 11% compounds to roughly 1.69x over five years, and the conservative case of about 8% compounds to roughly 1.47x. On the report's own numbers, revenue up 70-90% over five years is a more realistic target range than revenue doubling.

The growth that does exist is overwhelmingly volume-and-mix driven, not price-driven, and there is no genuine new-business contributor. Semiconductor revenue, the fastest-growing piece at 58.7% of 2025 sales, rose 22.0% in 2025 on what the report frames as fab-qualification ramp — more tonnes shipped to more approved lines — rather than pricing power; the industry structure the report describes has downstream customers (chipmakers, panel makers, solar-cell producers) setting the pace of qualification and controlling bargaining power, which caps supplier pricing leverage almost by design. Photoresist-supporting chemicals, the higher-margin product line, grew 14.1% and carried a 30.7% gross margin versus 26.1% for ultra-pure reagents, so there is a real mix tailwind, but that line is still only 36% of revenue, so its faster growth moves the blended number only at the margin. The closest thing to a "new business" contributor, a 37,000-tonne Zhenjiang project chasing the top SEMI G5 purity grade, is a depth upgrade within the same wet-chemicals category serving the same customer types, not a new product line with its own separate demand curve.

Working against all of this, display (37.6% of revenue) grew only 5.6% and solar (3.6%) fell 20.5% and was slightly loss-making at the gross level — together roughly 41% of the revenue base contributing close to nothing or actively subtracting from growth. For revenue to double, semiconductor would need to keep compounding near its current +22% pace for the full five years, the drag segments would need to stop dragging, and the Zhenjiang capacity would need to ramp smoothly into revenue — a stack of conditions beyond what even the report's own optimistic scenario assumes.

Jul 26, 2026
Five years out, what takes over as the next growth engine? Does that “second curve” exist today?3/10

No credible second curve exists inside Jianghua Micro today; what exists is a depth upgrade to the first one. The clearest candidate the record offers is the shift toward photoresist-supporting chemicals — 36% of 2025 revenue, growing 14.1% and carrying a 30.7% gross margin versus 26.1% for the ultra-pure reagents that still make up 64% of sales — but that is a mix improvement inside the existing wet-chemicals business, sold to the same semiconductor, display and solar customers Jianghua already serves, not a new engine with its own demand curve.

The next-closest candidate is the Zhenjiang subsidiary's 37,000-tonne ultra-high-purity project, a CNY 288.83 million investment that received environmental-assessment approval and, in 2025, put a phase-two slice into production making SEMI G5-grade isopropanol, ammonia water and hydrogen peroxide — the industry's highest purity tier, aimed at 12-inch wafer fabrication across mature and advanced nodes. That is a genuine technology-depth push, and unlike a slide-deck promise it already has initial output, but it is still wet chemicals sold into the same end markets through the same qualification-driven sales motion. It extends how far up the value chain Jianghua can sell, rather than opening a market the company is not already in. R&D spending backs up that this is where the incremental effort is going: full-year 2025 R&D expense rose 18.31% to about CNY 69.46 million, faster than the 12.3% revenue growth rate and reaching 5.63% of sales, per financial-press analysis of the 2025 annual report — a reasonable reinvestment signal, but one funding purity-grade and process depth within the existing category, not new-market R&D.

Two other candidates that a growth investor would want to exist mostly do not, at least not yet. There is no visible geographic second curve: nothing in the report or in the public record points to meaningful overseas revenue or an international expansion plan. And there is no adjacent-category second curve — no CMP slurries, no precursor chemistries, no battery or life-science chemicals push comparable to what a broader materials platform like Anji Micro has built. The one wildcard is the pending ownership transition to Shanghai state capital, which could in theory open new customer relationships, financing channels, or industrial resources that function as a genuine second engine — but the report is explicit that this "remains a possibility, not a result," and as of the most recent public filings the transfer itself was still working through Shanghai Stock Exchange compliance confirmation and share-registration steps, well short of a strategy anyone can evaluate yet.

The honest answer is that five years from now, Jianghua Micro's next engine is more likely to be a higher-purity, higher-margin version of what it already does than a genuinely new market — a reasonable, incremental path, but not the kind of second curve that alone would justify today's valuation.

Jul 26, 2026
What is its core competitive advantage? Will that moat widen or narrow over the next three to five years?4/10

The moat is real but shallow, and its trajectory over the next three to five years looks like slow widening at the edges rather than deepening. The durable part is qualification-based stickiness: the report is explicit that certification cycles are long and that once a supplier is approved, replacement is slow because wet chemicals are "low-cost in customers' total bill of materials but high-risk in yield impact." Jianghua Micro also has genuine breadth — one of a small number of domestic suppliers able to serve semiconductor, display and new-energy customers with a full wet-chemistry lineup, backed by regional service density in the Yangtze River Delta and a Sichuan base for western China.

What that moat has not yet produced is pricing power, and pricing power is the honest test of moat quality. 2025 ROE was 5.44% and net margin was about 8.5% — both explicitly below what the report calls "a deep, pricing-power-heavy moat" would show. The clearest evidence that the industry can support a much stronger moat than Jianghua's comes from its own named peers: Anji Micro, with deeper CMP and advanced wet-process chemistry, posted 2025 net profit of CNY 783.6 million on CNY 2.504 billion of revenue, a net margin near 31% — roughly 3.7x Jianghua's margin — while Shanghai Sinyang, a broader and more semiconductor-pure platform, posted 2025 net profit of CNY 301 million on CNY 1.937 billion of revenue (net margin near 15.5%), with profit up 71.12% year on year against Jianghua's 6.3%. Both peers prove the ceiling is higher than Jianghua has reached; neither result is Jianghua's today.

The forward-looking pushes are modestly positive: the photoresist-supporting chemicals line (36% of revenue, 30.7% gross margin versus 26.1% for reagents) is growing faster than the reagents base and, if that mix keeps shifting, should lift blended returns gradually; the Zhenjiang project's move into SEMI G5-grade output adds a genuine technology-depth credential that is harder for lower-tier competitors to replicate. The pulls in the other direction are structural rather than company-specific: the report notes downstream customers — chipmakers, panel makers, solar-cell producers — set the pace of qualification and hold the bargaining power, so "critical inputs are not automatically high-margin businesses"; rising financial expense (interest expense more than doubled in Q1 2026) signals the capital intensity of staying qualified and expanding capacity; and the unresolved ownership transition is an open question about capital-allocation focus during exactly the window this moat would need to deepen.

Net, the qualification-based retention moat is structural and unlikely to narrow much either way over three to five years — customers who are already qualified are not going to switch casually regardless of who owns Jianghua. But the moat's economic quality, measured the only way that matters — margin and ROE — is improving only gradually through mix shift, not through the kind of technology or pricing advantage that has let Anji and Shanghai Sinyang pull meaningfully ahead. Absent a step-change, that gap likely persists rather than closes.

Jul 26, 2026
If its core business were disrupted, does it have the DNA to reinvent itself? How does it handle mistakes and bad news?3/10

There is no direct crisis-response case study in the record to test this against, which is worth saying plainly rather than papering over: unlike companies that have lived through a public product recall, a restatement, or a demand collapse, nothing in Jianghua Micro's history rises to that level, so any answer here is inferred from adjacent evidence rather than observed under real fire.

What the operating record does show is moderate resilience through a genuinely difficult stretch. Operating cash flow was negative in 2021 (−CNY 49.3 million) during a capacity-building, working-capital-hungry period, and the company kept investing and scaling revenue anyway rather than retrenching; cash generation then rebuilt steadily to CNY 122.4 million (2022), CNY 145.6 million (2023), CNY 106.3 million (2024) and CNY 182.0 million (2025) — financial press coverage specifically flagged operating cash flow "surging" roughly 71% year on year in 2025 even as ROE kept declining. That is evidence of getting through a hard multi-year patch without abandoning the underlying strategy, which counts for something, though it reads as steady operational grinding rather than a bold reinvention.

The one concrete "how does it handle a complication" data point available is the February 2026 termination of the company's own simplified private placement once the pending ownership change complicated the picture — the report notes it was withdrawn before filing materials with the exchange or the CSRC, rather than pushed through under a cloud. That reads as reasonably disciplined, though it plausibly reflects pressure from the incoming acquirer and regulatory posture as much as a purely voluntary show of prudence, so it should not be over-credited as proof of strong independent crisis judgment. On the negative side of the ledger, there is nothing to report either: a direct check of the company's public regulatory-sanctions record turned up no listed censures or warnings, and the most recent safety-related disclosure is a routine production-license renewal for expanded Zhenjiang capacity rather than an incident.

The bigger uncertainty is about who would actually make the "core business disrupted, how do we respond" call going forward. Founder Yin Fuhua, who has run the company through every stage described in this report since founding it in 2001, has been a steady net seller of his own stock since April 2022, down to a 13.63% stake (52,568,237 shares) by late December 2025, including a two-day sale of 928,200 shares for CNY 16.8354 million that same month, while control of the company is passing from one external state-capital owner (Zibo) to a second (Shanghai) whose operating instincts are, in the report's own words, "process, not proof" so far. The institutional memory that has shown some adaptability over two decades is not the entity that will hold the pen if a real disruption hits next.

The honest summary is a cautious, unproven-leaning-neutral verdict: no red flags, some evidence of quiet resilience, but no test of genuine self-reinvention and a governance structure in flux at exactly the moment that capability would need to be exercised.

Jul 26, 2026
Does management — the founders especially — hold a long-term view with interests deeply tied to the company? Are they willing to sacrifice current profit for the payoff five to ten years out?3/10

The record does not support a founder-aligned, decade-thinking management profile, and the direction of travel over the past four years has been away from that picture rather than toward it. Yin Fuhua has run Jianghua Micro since founding it in Jiangyin in 2001, spent 15 years before that at the predecessor Jiangyin Chemical Reagent Factory, and remains Chairman and General Manager today — a genuine, long-tenured industry builder rather than a financial engineer, and that tenure is a real point in his favor. At the 2017 IPO he held 36.559% of the company directly.

Two things have changed since. First, by 2025 the company's controlling shareholder of record was already Zibo Xingheng Tusong, a Zibo state-capital vehicle, not the founder — meaning founder-level control had already been ceded before the period this report covers. That Zibo stake is now itself being sold to a second external owner: in January 2026 Zibo Xingheng Tusong agreed to sell 92.38 million shares (23.96% of the company) to Shanghai Fuxun Technology for CNY 20 per share, a CNY 1.848 billion transaction with a five-year lock-up that would shift ultimate control to the Shanghai State-owned Assets Supervision and Administration Commission. As of the most recent public progress disclosure, that deal had received a Zibo Municipal Finance Bureau sign-off but still awaited Shanghai Stock Exchange compliance confirmation and share-registration steps — not yet closed.

Second, and separately, Yin's own economic stake has been shrinking on its own track. He began selling down on April 11, 2022, and by December 24, 2025 held 52,568,237 shares, or 13.63% — including a two-day sale of 928,200 shares for CNY 16.8354 million in December 2025 alone, against a disclosed 2025 annual salary of CNY 1.3684 million, about 9.28 times average employee pay. A founder who has been a net seller for nearly four straight years, inside a company whose control is simultaneously passing between two different external state-capital owners in short succession, is a materially different picture from the founder-CEO-with-growing-skin-in-the-game profile this question is really asking about.

There is a real counterweight worth naming: capital allocation still looks oriented toward the multi-year build rather than short-term harvesting. Full-year 2025 R&D expense rose 18.31% to about CNY 69.46 million, faster than 12.3% revenue growth and reaching 5.63% of sales, and the company kept committing fresh capital to capacity — the CNY 288.83 million Zhenjiang G5-grade project, plus a further CNY 90 million self-funded injection into that same subsidiary disclosed in July 2026. No dividend or buyback is described in the report. That is consistent with an operator still building rather than one optimizing for a near-term exit.

Put together, this looks like a long-tenured operating founder with declining personal ownership, embedded inside a state-capital ownership structure now in its second handoff in a short window, whose new controller's actual strategic intentions remain, in the report's words, "process, not proof." That is not the founder-aligned, five-to-ten-year-sacrifice profile the framework is testing for.

Jul 26, 2026
If it disappeared tomorrow, how badly would customers miss it? Is the way it grows sustainable, without relying on harm to society or regulators?4/10

Customers would miss Jianghua Micro for a real but bounded period, not indefinitely, and the growth model itself looks legitimate rather than exploitative. On indispensability: the report is explicit that wet chemicals are "low-cost in customers' total bill of materials but high-risk in yield impact" once a supplier is qualified, so an abrupt disappearance would genuinely disrupt already-qualified fabs, panel makers and solar-cell producers — requalifying an alternate supplier takes time, and yield risk during that transition is real, not theoretical.

But that is a high-friction moat, not a high-dependency one, and the distinction matters for how much customers would actually miss this specific company. Jianghua is one of several credible qualified suppliers rather than a chokepoint: the report's own peer set names Shanghai Sinyang, Anji Micro and Greenda domestically, alongside global references like Avantor and Japan's Kanto Denka. And 64% of Jianghua's own revenue sits in ultra-pure reagents — the report's own more commodity-like, lower-differentiation tier, carrying a 26.1% gross margin versus 30.7% for the harder-to-replicate photoresist-supporting chemistries. A 5.44% ROE and sub-9% net margin are themselves evidence of a price-taker rather than a price-setter: if Jianghua's specific output were genuinely irreplaceable, that scarcity should show up in margin, and it largely does not. The Semiconductor Industry Association's own position — that certain process chemistries, particularly fluorinated/PFAS-based materials and specific solvents like GBL and BDO, have no known functional alternatives — supports how critical the wet-chemicals category is industry-wide, not that Jianghua specifically is irreplaceable as a supplier within it. As the report itself puts it, "critical inputs are not automatically high-margin businesses," and the same logic caps indispensability at the company level even where it is high at the category level.

On sustainability: the growth model is import substitution running through a policy-supported channel, not extraction from customers or regulatory arbitrage. The same 2025-2026 Ministry of Industry and Information Technology plan that backs China's broader electronic-chemicals substitution push applies directly to Jianghua's core business, and a direct check of the company's public regulatory-sanctions record turned up no listed censures or warnings. The most recent safety-related disclosure is a routine production-license renewal covering expanded Zhenjiang capacity, not a violation. The one caveat worth stating clearly: this is a chemical manufacturer handling corrosive, hazardous ultra-pure reagents at expanding scale — capacity is growing toward roughly 130,000 tonnes a year across sites — and that carries an inherent, industry-wide environmental and workplace-safety tail risk worth monitoring on an ongoing basis, even though nothing in the current record singles Jianghua out as a bad actor on that front.

The honest summary: real but moderate indispensability — months to a couple of years of disruption for currently-qualified customers, not a permanent hole — inside a growth model that looks sustainable and policy-aligned rather than harmful, with a generic chemical-industry safety risk that applies to the sector as much as to this company specifically.

Jul 26, 2026
What are the unit economics of this business (gross margin, incremental returns)? Do they get better or worse at scale? Where does the money it earns go?3/10

Jianghua Micro's unit economics are real but structurally unremarkable, and the most important fact in this answer is that scale has not, so far, translated into better returns on capital — if anything the trend runs the other way. Blended gross margin on the main business was 27.79% in 2025, splitting into 26.1% for ultra-pure reagents (64% of revenue) and 30.7% for photoresist-supporting chemicals (36% of revenue), a 4.58-point spread the company itself tracks. By end market, semiconductor carried the best gross margin at 29.3% and was also the fastest-growing segment (+22.0%), while solar was "slightly loss-making at the gross level" as its revenue fell 20.5% — the strongest and weakest pockets are moving in opposite directions, and the weak one, while small at 3.6% of revenue, is still a live drag rather than something that has been cut loose.

The return-on-capital trend is the least reassuring part of the picture. ROE peaked at 9.68% in 2022 and has fallen every year since — 6.27% (2023), 6.35% (2024), 5.44% (2025) — even as revenue grew from CNY 939.2 million to CNY 1,233.8 million over the same stretch, a 31% increase. Getting bigger has not meant getting more profitable on the capital already employed. Near-term operating leverage points the same direction: 2025 revenue grew 12.3% while net profit grew only 6.3%, and Q1 2026 repeated the pattern (revenue +16.9%, profit +7.3%), with full-year 2025 R&D expense up 18.31% to about CNY 69.46 million and Q1 2026 financial expense more than tripling as interest costs rose. Financial press coverage of the 2025 annual report captured this exact divergence in its own headline: operating cash flow surging roughly 71% year on year even as ROE kept declining.

That divergence is also the genuinely encouraging half of the story. Operating cash flow reached CNY 182.0 million in 2025 against CNY 104.8 million of net profit — a 1.74x ratio — up from CNY 106.3 million in 2024 and negative cash flow as recently as 2021. Cash quality is improving even where the income-statement margin story is only crawling forward, which suggests working-capital discipline (receivables, inventory) has gotten meaningfully better, independent of whether pricing power has.

Where the cash goes answers the "spent on what" half of the question plainly: not shareholders. Reported 2025 cash capex was a modest CNY 27.0 million against roughly CNY 118.8 million of depreciation, the balance sheet carried CNY 525.6 million of cash against CNY 442.5 million of borrowings (gross debt-to-equity near 22%), and the larger capital commitments sit off the trailing P&L — the CNY 288.83 million Zhenjiang G5-grade project and a further CNY 90 million self-funded injection into that subsidiary disclosed in July 2026. No dividend or buyback appears anywhere in the record. Cash is being retained and redeployed into more capacity for the same kind of business, which is a defensible choice for a company still building out its highest-margin segment, but it is not yet evidence that the business gets structurally better as it gets bigger.

Jul 26, 2026
For it to rise fivefold in ten years, what conditions must all hold at once? Are they realistic? What expectations does today's share price already imply?2/10
A
A ten-year five-bagger from the CNY 32.24 anchor price means reaching about CNY 161.20 a share, which requires a sustained annualized return near 17.5% for a full decade (5^(1/10) − 1 ≈ 17.46%). Nothing in the report's own work gets close to that pace, and the report's own scenario table, which only runs out to 2028, already lands below today's price even in its most optimistic case: an optimistic-case value of CNY 24-28 per share built on roughly CNY 210 million of 2028 owner earnings at a 50x multiple. The report says this outright — "even the optimistic case produces a value range below the 2026-07-24 close" — which is close to a direct answer to this question on its own.

Running the owner-earnings math out to a full decade makes the gap concrete. The report's own "generous" 2025 owner-earnings estimate is about CNY 117 million, or roughly CNY 0.30 per share on 385.64 million shares outstanding. For the stock to reach CNY 161.20 in ten years:
- At a 40x terminal multiple (the report's own conservative-case multiple), owner earnings would need to reach about CNY 4.03 per share — roughly 13.3x today's base, an annual growth rate near 29-30% sustained for ten straight years.
- At 60x (above every current domestic peer multiple except Jianghua's own), about CNY 2.69 per share is needed — an 8.9x increase, or roughly 24% a year for ten years.
- Even if the market kept paying today's rich ~116x-119x multiple unchanged for the entire decade — an assumption the report's whole thesis argues against — owner earnings would still need to compound at essentially the same ~17.5% pace as the stock price target itself, since price return equals earnings growth when the multiple does not move.
All three paths sit well above anything the report's own scenario work supports. Even the optimistic case models only a ~14% revenue CAGR through 2028 and net margin topping out near 11-12%, which implies profit growth in the high teens at best over the near term — not the high-20s-to-30%-a-year compounding that a five-bagger requires sustained for a full decade.

What today's price already implies is arguably the more important half of this answer. At CNY 32.24, Jianghua trades around 116x-119x trailing earnings — above Shanghai Sinyang's roughly 83x, despite Sinyang growing 2025 revenue 31.28% and net profit 71.12% year on year, more than five times Jianghua's own 12.3%/6.3% growth; above Anji Micro's roughly 71x, despite Anji's net margin near 31% versus Jianghua's 8.5%; and above Greenda's roughly 63x. Today's price is not pricing in modest, credible success — it is already pricing in more optimism than any of the three better-growing, better-margined domestic peers currently receive.

The honest conclusion is that a ten-year five-bagger is not a realistic reading of this setup. It would require owner earnings compounding at two to three times the pace embedded in the report's own optimistic near-term scenario, sustained for a full decade, while the market simultaneously pays a richer multiple than any comparable peer commands today for a far weaker growth-and-margin profile. The report's own numbers already answer "what does today's price imply" — a lot more than the business has delivered so far — before the ten-year question is even asked.
Jul 26, 2026
Why hasn't the market grasped all this yet — does it not understand, not respect it, or not see far enough? What would become the “narrative inflection point”?2/10

The premise behind this question — that the market has not noticed — does not fit the facts here, and the honest answer inverts the usual framing: this looks much more like a market that noticed enthusiastically, arguably over-noticed, and has already begun correcting. The stock ran to a record CNY 59.50 on 2026-07-03, a one-year gain above 70% at the peak per the report, then fell back roughly 46% to CNY 32.24 by 2026-07-24 — independent reporting confirms the stock was trading in almost exactly that zone that week, including a CNY 56.26 close on 2026-07-03 tied to a control-transfer-progress disclosure, corroborating both the scale of the run-up and the speed of the pullback. That price pattern is not the signature of a name sitting undiscovered; it is the signature of a name that got a lot of attention very quickly and is now giving some of it back.

Cross-sectional evidence points the same way. Jianghua trades at roughly 116x-119x trailing earnings versus Shanghai Sinyang's ~83x (even though Sinyang grew 2025 revenue 31.28% and net profit 71.12%, both far faster than Jianghua's 12.3%/6.3%), Anji Micro's ~71x (with roughly 31% net margin against Jianghua's 8.5%), and Greenda's ~63x. If the market were systematically overlooking Jianghua's story the way this question assumes, it would likely trade at a discount to these stronger, faster-compounding peers, not the richest multiple of the four. Paying the highest price for the slowest growth and thinnest margin in its own peer set is closer to over-attention than under-attention.

What likely happened is a mix of real and speculative narratives running together and getting priced faster than the fundamentals could keep up: real improvement (semiconductor becoming the largest end market, operating cash flow strengthening to CNY 182.0 million) blended with speculative, event-driven excitement around the Shanghai-state-capital ownership change, which gives momentum traders something to trade on a news cycle that has nothing to do with quarterly earnings. Thin float in a small-cap A-share name plausibly amplified both the run-up and the subsequent air pocket.

Given that, the more probable next "narrative inflection point" is a downside-clarifying one rather than an upside-discovery one. The control transfer itself is still incomplete — the most recent public filing showed only a Zibo Municipal Finance Bureau sign-off, with Shanghai Stock Exchange compliance confirmation and share-registration steps still outstanding — so the moment the new controller's actual post-transfer strategy becomes observable rather than speculative is a real catalyst, in either direction. Semiconductor growth normalizing from 22.0% toward the report's own flagged alert threshold of "below 10% for two consecutive quarters" is another. The next scheduled earnings release, expected around 2026-08-26, is the nearest concrete checkpoint. And simple multiple convergence toward the 63x-83x range the three better peers already trade at, especially uncomfortable given that the cheapest of those three peers is also the fastest-growing, is a standing structural pull.

The straight answer, stated plainly: this is not a hidden-gem setup the market has failed to find. It is closer to the opposite — a name the market has already priced with more optimism than its underlying growth and margin profile, relative to its own direct peers, currently supports, and if a real narrative shift is still coming, mean reversion toward peer multiples is the more likely direction than further upside discovery.

Jul 26, 2026

Ask about this report

Members can ask about this report; once answered it appears under "Reader Q&A" on this page. You can also highlight a passage in the text to ask about it directly.